NCT03835299 is a NA clinical trial of Fear Intervention in Blood Donors, sponsored by Ohio University.

Who is sponsoring NCT03835299?

NCT03835299 is sponsored by Ohio University.

What drugs are being tested in NCT03835299?

Interventions in NCT03835299: Fear Intervention.

What condition does NCT03835299 study?

NCT03835299 studies Blood Donors.

Is NCT03835299 still recruiting?

NCT03835299 is currently completed. Last updated 16 September 2021.

Last reviewed 2021-09-16 · How we verify

NCT03835299

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Addressing Fear and Risk of Vasovagal Reactions Among High School Donors

Completed NA Last updated 16 September 2021

What this trial tests

NA trial testing Fear Intervention in Blood Donors in 4,035 participants. Completed in 15 January 2020.

Timeline

15 February 2019

Primary endpoint
15 January 2020

15 January 2020

Quick facts

Lead sponsor	Ohio University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	4,035
Start date	15 February 2019
Primary completion	15 January 2020
Estimated completion	15 January 2020
Sites	1 location across United States

Drugs / interventions tested

Fear Intervention

Conditions studied

Blood Donors — all drugs for Blood Donors →

Sponsor

Ohio University

Who can join

16 and older, any sex, with Blood Donors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, high school donors will be asked about their blood donation-related fears prior to their donation. Half of the donors reporting fear will be assigned to a brief coping skills intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Donors

Currently open trials in the same condition.

NCT00001846 — Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use · recruiting

Other Ohio University trials

Trials by the same sponsor.

NCT06932016 — Treating Passive Structure Knowledge Deficits in School-Age Children With Developmental Language Disorder · NA · not yet recruiting
NCT07503899 — Older Adult Traditional Balance Training vs Traditional Balance Training Plus Neck Strengthening · NA · not yet recruiting
NCT06911138 — Treating Complex Grammar Knowledge Deficits in School-Age Children With Developmental Language Disorder · NA · recruiting
NCT06390072 — Project Hypnos: The Impact of a Brief Hypnosis Intervention on Single-limb Dynamic Balance in People With Chronic Ankle · NA · completed
NCT06350253 — Comparison Of Measured To Predicted Resting Metabolism · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03835299 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio University
Last refreshed: 16 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03835299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing